Laminins regulate diverse cellular functions through interaction with integrins. Two regions of laminins-three laminin globular domains of the a chain (LG1-3) and the carboxyl-terminal tail of the g chain (g-tail)-are required for integrin binding, but it remains unclear how the g-tail contributes to the binding. We determined the crystal structure of the integrin binding fragment of laminin-511, showing that the g-tail extends to the bottom face of LG1-3. Electron microscopic imaging combined with biochemical analyses showed that integrin binds to the bottom face of LG1-3 with the g1-tail apposed to the metal ion-dependent adhesion site (MIDAS) of integrin b1. These findings are consistent with a model in which the g-tail coordinates the metal ion in the MIDAS through its Glu residue.
INTRODUCTION
Adhesion of cells to the basement membrane (BM) is a fundamental biological process essential for tissue development and maintenance. Laminins make a major contribution to the cell-adhesive activity of the BM and elicit a variety of cellular responses through interaction with a panel of cell surface receptors, including integrins. Laminins consist of three chains, a, b, and g, which assemble into a cross-shaped heterotrimer. In mammals, 11 laminin chains (a1 to a5, b1 to b3, and g1 to g3) and 16 combinations of these have been identified (1) . Laminin-511 (LM511), an isoform consisting of chains a5, b1, and g1, is expressed in the early embryonic stage and maintains tissue homeostasis throughout life (2) . Integrins are heterodimeric membrane proteins composed of noncovalently associated a and b subunits (3) . Twenty-four integrins have been identified in mammals; among these, a6b1 integrin exhibits the highest binding affinity for the a5 chain-containing laminin isoforms LM511 and LM521 (4) .
The integrin binding activity of laminin has been mapped within the "E8" segment, comprising the distal part of the coiled-coil domain and three laminin globular domains (LG1-3) of the a chain (Fig. 1A , middle).
LG1-3, which are prerequisite for integrin binding (5) (6) (7) , have been proposed to adopt a "cloverleaf" configuration based on electron microscopic observations (8) , although LG1-3 alone adopted an open configuration when their structure was determined by x-ray crystallography (9) . LG1-3 alone have no significant integrin binding activity (10) , suggesting that b and/or g chains facilitate the cloverleaf assembly of LG1-3 for integrin recognition.
Our previous results showed that the Glu residue at the third position from the C terminus of the g chain is crucial for integrin binding (11, 12) . However, it remains to be determined whether this Glu residue in the C-terminal region of the g chain (designated the g-tail) contributes to adopting an active LG1-3 conformation for integrin recognition or directly interacts with integrins by coordinating the metal ion held in the major ligand-binding site of integrins. This site is referred to as the MIDAS (metal ion-dependent adhesion site). Here, we sought to determine the role of the g-tail in the laminin-integrin interaction by x-ray crystallography combined with electron microscopic imaging and a series of biochemical analyses.
RESULTS
Crystal structure of the integrin binding region of LM511 Through a series of truncation/deletion mutagenesis experiments coupled with evaluation of the integrin binding activity, we identified a truncated LM511E8 (tLM511E8) suitable for the structural determination, which was successfully crystallized and whose structure was determined at 1.8 Å resolution ( fig. S1 and table S1). The structure of tLM511E8 exhibited a "ladle" shape with LG1-3 adopting a compact triangular cloverleaf configuration, where LG1 was in direct contact with LG3 ( Fig. 1, A and C) . Each LG adopts a canonical b-sandwich fold stabilized by a conserved disulfide bridge typical for this class of domain. We found one calcium ion at the LG1-LG3 interface (Fig.  1B) , where its octahedrally coordinating ligands were provided by both LG1 (four ligands) and LG3 (one ligand), as well as one water molecule. The overall arrangement of LG1-3 is in sharp contrast to that seen in the same fragment of a2 chain previously reported in isolation, which adopted an open configuration with LG1 completely dissociated from LG3 (9) . Thus, the cloverleaf assembly of LG1-3 in tLM511E8 should have been brought about by the heterotrimeric assembly of the a5 chain with a b1-g1 dimer, rather than by the direct contact between LG1 and LG3 (Fig. 1D) . Notably, LG1 and LG2 clamp the C-terminal region of the b1-g1 dimer ( Fig. 2A). LG1 contains a hydrophobic patch consisting of residues V2733, V2735, P2736, Y2913, F2915, L2921, and P2928 (Fig.  2B) . Following the heterotrimeric assembly, the hydrophobic patch is brought into direct contact with the side chains of Y1782 of the b1 chain and L1596/P1597/F1601 of the g1 chain. As a result, LG1 is fastened to the C-terminal region of the b1-g1 dimer through hydrophobic sidechain interactions (Fig. 2C). LG2 faces the b1 chain pillar from the opposite side, but there are no obvious side-chain interactions at the interface. Instead, water molecules fill the gap by forming a hydrogenbonded network and secure the contacts of LG2 with the b1-g1 dimer (Fig. 2D) . Thus, heterotrimeric assembly may impose conformational restriction on LG1 and LG2 to appose the b1 chain pillar and lead to the cloverleaf assembly of LG1-3.
It has been proposed that the Glu residue in the g-tail associates with LG1-3 to ensure their functional triangular assembly (5) . However, the five C-terminal residues of the g1 chain, including E1607 (g1E1607), which is the critical residue for integrin binding, are disordered in our structure and have no direct contact with LG1-3 ( Fig. 2 and fig. S2B ), strongly arguing against its role in stabilizing the functionally active conformation of LG1-3. Recently, Pulido et al. (13) reported a highresolution crystal structure of the integrin binding region of mouse LM111. The global structure of LM111 is essentially the same as that of LM511 shown here, with both LM111 and LM511 exhibiting a triangular configuration of LG1-3 with the b1-g1 dimer clamped between LG1 and LG2. One interesting difference is that the LG3 in LM111 is positioned to make the transverse plane of LG1-3 orthogonal to the coiled-coil domain, whereas LG3 in LM511 forms a beveled plane of LG1-3 ( fig. S2A) . Nevertheless, the g1-tail in the LM111 structure is oriented toward the bottom face of LG1/LG2 with the side chain of E1605 (equivalent to g1E1607 in human) and the following residues disordered in the crystal structure ( fig. S2B ), as in our human tLM511E8 structure.
LM511 binds to a6b1 integrin in a bottom-to-head manner The ligand-binding site of integrins has been mapped to the upper face of the integrin's headpiece that consists of the b-propeller domain of the a subunit and the bI/hybrid domains of the b subunit (3). It is generally accepted that recognition of physiological ligands by integrins relies on an acidic residue in the ligands, coordinating a divalent metal ion in the MIDAS of the integrin b subunit (b-MIDAS) (14) . Consistent with this scheme, the Glu residues in the g1-tail (E1607) and g2-tail (E1191) are essential for integrin binding by laminins; the g3 chain does not have an equivalent Glu residue (11, 12) . Furthermore, our exhaustive survey demonstrated that no single acidic residue in the LM511E8 fragment other than g1E1607 is critically required for integrin binding (15) , pointing toward the possibility that g1E1607 directly coordinates with the b-MIDAS. To gain insight into the location of the integrin binding site within LM511, we examined LM511E8 complexed with recombinant a6b1 integrin by electron microscopy. A gallery of electron microscopic images revealed that the headpiece of a6b1 integrin always bound to LM511E8 at the site opposite the filament-like coiled-coil extension (Fig. 3A and fig. S3 ). These results indicate that LM511 binds to a6b1 integrin via the bottom face of LG1-3, where the disordered five C-terminal residues of the g1-tail are predicted to reside (Fig. 3B ). LG3
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LG2 The g1-tail is positioned close to the metal ion of the b1-MIDAS To further clarify the possibility that the g1-tail directly interacts with a6b1 integrin, we simultaneously introduced Cys substitutions into the g1-tail and the bI domain of integrin b1 and then performed exhaustive screening for intermolecular disulfide formation between the Cyssubstituted LM511E8 and the a6b1 integrin. We reasoned that a Cys residue introduced adjacent to g1E1607 would become crosslinked to a Cys residue introduced near the b1-MIDAS if the g1-tail directly interacts with integrin b1. Thus, we introduced Cys substitutions of residues I1606 and K1608 of the g1-tail ( Fig. 3C ) and of 19 residues in the bI domain that are predicted to be surface-exposed near the b1-MIDAS ( fig. S4 ). LM511E8 with g1-I1606C and g1-K1608C substitutions (designated LM511E8/I1606C and LM511E8/ K1608C, respectively) retained integrin binding activity, whereas those having additional Gln substitutions for g1E1607 (designated LM511E8/ I1606C/EQ and LM511E8/K1608C/EQ) were almost devoid of the activity ( fig. S5 ). Coexpression of Cys-substituted LM511E8 and a6b1 integrin in mammalian cells and subsequent immunoprecipitation of secreted LM511E8, followed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) under nonreducing conditions, identified a total of seven disulfide-linked products between LM511E8 and a6b1 integrin, depending on the position of the Cys substitution near the b1-MIDAS (Fig. 3 , D and E, and fig. S6 ). LM511E8/I1606C was disulfide-linked to four Cys-substituted integrin b1 residues: 133, 221, 222, and 223 ( Fig. 3E , top); LM511E8/K1608C was disulfide-linked to three Cyssubstituted residues: 133, 223, and 225 ( Fig. 3E , bottom). The ability of both laminin mutants to form disulfide bonds with integrin b1 residues 133 and 223 is consistent with the fact that these residues are closest to the MIDAS metal ion, where g1E1607 is predicted to ligate (Fig. 3D ). In contrast, residues 221 and 222, which are located further away from the a subunit, preferentially cross-linked to LM511E8/ I1606C, whereas residue 225, situated closer to the a subunit, efficiently cross-linked to LM511E8/K1608C. These results suggest that the I1606-E1607-K1608 segment of the g1-tail is aligned parallel to the segment with residues 221 to 225 of the a2-a3 loop of integrin b1, with the C-terminal end of the former pointing toward the b-propeller domain of integrin a6 when g1E1607 coordinates with the b1-MIDAS metal ion ( Fig. 3F , top). This is in sharp contrast to the common mode of ArgGly-Asp (RGD) motif recognition by many integrins, where a short peptide segment is docked at the a-b interface in the N→C direction, with the side chains of Arg and Asp being recognized by the a and b subunits of integrins, respectively (Fig. 3F , bottom) (16) (17) (18) .
To confirm the specificity of the intermolecular disulfide formation between the Cys-substituted LM511E8 and the a6b1 integrin, we performed the disulfide cross-link assays using laminin mutants carrying the inactivating Gln mutation at g1E1607 (fig. S7 ). The Gln substitution resulted in a significant reduction in the disulfide formation, suggesting that efficient disulfide bond formation requires correct steering of the g1-tail guided by the g1E1607-MIDAS interaction. It is also notable that intermolecular disulfide bonds, particularly involving integrin b1 residue 133, form to some extent in the absence of g1E1607, suggesting that LM511E8 devoid of g1E1607 has weak but appreciable binding ability to integrin.
g1-Tail-derived peptide inhibits laminin-integrin interaction Although these results strongly support the idea that the g1-tail comprises the integrin binding site of LM511 and directly interacts with the b1-MIDAS of a6b1 integrin, we have been unable to show competitive inhibition of integrin-ligand interaction using synthetic peptides derived from the g1-tail (11), which has been repeatedly observed in RGD-recognizing integrins with RGD and related peptides (19) . To revisit the effect of synthetic g1-tail peptides on laminin-integrin interactions, we performed inhibition assays using a g1-tail-derived pentapeptide SIEKP (designated g1C5) and its E-to-Q mutant (SIQKP) under conditions where a6b1 integrin was rendered conformationally 
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Takizawa et al., Sci. Adv. 2017; 3 : e1701497active by the activating anti-integrin b1 antibody TS2/16. g1C5 was only weakly inhibitory to a6b1 integrin binding to LM511E8 in the absence of TS2/16, but it exerted a significant inhibitory activity in the presence of TS2/16 [half-maximal inhibitory concentration (IC 50 ) approximately 25 mM] (Fig. 4A) . The inhibitory activity of g1C5 was abrogated by the E-to-Q substitution, lending support to the idea of direct interaction of the g1-tail with a6b1 integrin in a g1E1607-dependent manner.
DISCUSSION
Despite the requirement for the Glu residue within the g-tail in integrin recognition by laminins, it has remained unsettled whether the g-tail is required for the maintenance of a functionally active conformation of LG1-3 of the a chain or whether it directly interacts with integrin by coordinating the metal ion in the b-MIDAS. Several lines of evidence obtained in this study support the latter possibility. First, the g1-tail of tLM511E8 was found disordered in the crystallized structure and therefore does not seem to contribute significantly to the maintenance of LG1-3 conformation. The C-terminal region of the b1-g1 dimer is clamped between LG1 and LG2, suggesting that the disordered g1-tail extends to the bottom face of the ladle-shaped tLM511E8. Second, electron microscopic imaging of LM511E8 complexed with a6b1 integrin revealed that LM511E8 binds to the integrin in a bottom-to-head manner, consistent with the prediction that the disordered g1-tail 
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Takizawa et al., Sci. Adv. 2017; 3 : e1701497lies at the bottom face of LG1-3. Third, intermolecular disulfide crosslink screening with a panel of Cys-substituted LM511E8s and a6b1 integrins demonstrated that the g1-tail is selectively disulfide-linked to residues near the b1-MIDAS, supporting the idea of direct interaction of the g1-tail with integrin's b1-MIDAS. Finally, the g1C5 peptide SIEKP inhibited the binding of LM511E8 to a6b1 integrin, but its E-to-Q mutant did not, corroborating the direct interaction of the g1-tail with a6b1 integrin, in which g1E1607 is prerequisite. Together, these findings lead us to conclude that the g1-tail directly interacts with integrin's b1-MIDAS, with g1E1607 serving as the critical acidic residue that coordinates the metal ion in the b1-MIDAS.
There is compelling evidence that LG1-3 is required for laminin recognition by integrins. Deletion of LG1-3 or substitution of any one of the LGs nullifies the integrin binding activity of laminins (10, 20) . Furthermore, the integrin binding specificity, as well as the affinity of laminin isoforms, has been shown to be primarily defined by the laminin a chains (4). In support of the involvement of LG1-3 in laminin recognition by integrins, the LM511E8 mutant lacking the five C-terminal residues of the g1-tail competitively inhibited the binding of a6b1 integrin to LM511E8, albeit at a much higher concentration than intact E8 ( fig. S8 ). Given that LM511E8 binds to a6b1 integrin in a bottom-tohead manner, it is conceivable that LG1-3 harbor an auxiliary integrin recognition site(s) at their bottom face that can complement the primary site involving the g1-tail, although the detailed location of this site(s) remains to be explored. Pulido et al. (13) noted that the LG1 and
LG2 surfaces on either side of the g1-tail are more highly conserved than that of LG3, implying that the residues involved in integrin binding lie within the highly conserved surfaces. Our exhaustive disulfide crosslink screening with Cys-substituted LM511E8 and a6b1 integrin showed that the g1-tail came into close contact with and cross-linked with integrin b1 residue 133 near the b1-MIDAS even in the absence of g1E1607. These findings suggest that the interaction of a6b1 integrin with the bottom face of LG1-3 brings the g1-tail into close contact with the b1-MIDAS, thereby stabilizing the laminin-integrin complex (Fig. 4B) .
In conclusion, we report evidence that supports a scheme in which the g1-tail directly interacts with integrin b1, with g1E1607 coordinating the metal ion in the b1-MIDAS during formation of the LM511-a 6b1 integrin complex. These findings contribute to a better understanding of the molecular basis of laminin-integrin interactions in diverse aspects of cellular function.
MATERIALS AND METHODS

Antibodies and reagents
Horseradish peroxidase (HRP)-conjugated mouse anti-5×His mAb was from Qiagen. Monoclonal ANTI-FLAG M2 antibody was purchased from Sigma-Aldrich. HRP-conjugated mouse anti-c-Myc mAb (clone 9E10) was purchased from Abcam. Rabbit polyclonal antibody (pAb) against the ACID/BASE coiled-coil region (designated Velcro) was produced by immunization with ACID/BASE coiled-coil peptides, as described previously (21) . The anti-Velcro pAb was biotinylated using EZ-Link Sulfo-NHS-Biotin reagents (Thermo Fisher Scientific) according to the manufacturer's instructions. mAb 5D6 against the human laminin a5 chain was generated in our laboratory, as described previously (22) . mAb 4C7 against the LG of human laminin a5 chain (10, 23, 24) was from Merck Millipore. Mouse immunoglobulin G (IgG) was from Thermo Fisher Scientific. HRP-conjugated goat anti-mouse IgG pAb was purchased from Jackson ImmunoResearch. HRP-conjugated streptavidin was from Thermo Fisher Scientific. The mAb TS2/16 against human integrin b1 was purified on a Protein G Sepharose 4 Fast Flow column (GE Healthcare) from the conditioned media of hybridoma cells obtained from the American Type Culture Collection. Restriction enzymes Nhe I, Bam HI, and Not I were obtained from New England BioLabs. AcTEV protease, which is an enhanced form of tobacco etch virus (TEV) protease, was purchased from Thermo Fisher Scientific. Synthetic peptides derived from the five C-terminal residues of the human laminin g1 chain, namely, g1C5 and g1C5 (EQ), were purchased from Greiner Bio-One.
Construction of expression vectors
Expression vectors for recombinant E8 fragments of human laminin a5, b1, g1, and g1 having a Gln substitution for g1E1607 were prepared as described (11) . 6×His, hemagglutinin (HA), and FLAG tags were added to the N termini of LMa5E8, LMb1E8, and LMg1E8, respectively. An expression vector for LMa5E8 in which the 6×His tag was replaced with a c-Myc tag was generated by extension polymerase chain reaction (PCR) using 6×His tag-conjugated LMa5E8 expression vector as the template. Expression vectors for LMg1E8/I1606C, LMg1E8/I1606C/ EQ, LMg1E8/K1608C, and LMg1E8/K1608C/EQ were generated by extension PCR, using LMg1E8 and LMg1E8/EQ expression vectors as templates. The pcDNA3.4+MCS vector was generated by inserting the multiple cloning site sequence derived from the expression vector pSecTag2A into the TOPO cloning site of pcDNA3.4-TOPO (Thermo Fisher Scientific).
Expression vectors for individual truncated-E8 fragments of human laminin a5, b1, and g1 chains (designated tLMa5E8, tLMb1E8, and tLMg1E8, respectively) were constructed as follows. Complementary DNAs encoding tLMa5E8 (E2655-A3327), tLMb1E8 (D1714-L1786), and tLMg1E8 (D1528-P1609) were amplified by PCR using individual E8 expression vectors as templates. The PCR products were digested with Nhe I and Not I and then ligated into the Nhe I-Not I sites, that is, between the Nhe site and the Not I site, of pcDNA3.4+MCS. 6×His, HA, and FLAG tags, followed by a TEV protease recognition sequence, were added by extension PCR. The PCR products were digested with Nhe I/Not I and inserted into the corresponding restriction sites of pcDNA3.4+MCS. tLMa5E8/I2723C and tLMg1E8/D1585C mutants were generated by extension PCR using tLMa5E8 and tLMg1E8 expression vectors as templates, respectively. The PCR products were digested with Nhe I/Not I and inserted into the corresponding restriction sites of pcDNA3.4+MCS.
An expression vector for the extracellular domain of human integrin a6 with C-terminal ACID peptide and FLAG tag sequences was prepared as described previously (10) . An expression vector for the extracellular domain of human integrin b1 with a BASE peptide and a 6×His tag sequence at the C terminus was prepared as described previously (21) . Expression vectors for integrin b1 mutants, in which 19 residues located on the I-like domain were individually Cys-substituted, were produced by extension PCR, using integrin b1 expression vector as the template. The PCR products were digested with Bam HI/Not I and cloned into the same sites of the wild-type construct. All DNA sequences were verified using ABI PRISM 3130xl Genetic Analyzer (Thermo Fisher Scientific).
Expression and purification of recombinant proteins LM511E8 was transiently expressed in FreeStyle 293-F cells (Thermo Fisher Scientific) according to the manufacturer's instructions. Conditioned media were collected 72 hours after transfection and loaded onto cOmplete His-Tag Purification Resin (Roche). The resin was washed with Hepes-buffered saline (HBS) (8.0) [20 mM Hepes and 137 mM NaCl (pH 8.0)], and the protein was eluted with HBS (8.0) containing 250 mM imidazole. Fractions containing LM511E8 were further loaded onto DDDDK-tagged Protein Purification Gel (MBL). The resin was washed with HBS (7.4) [20 mM Hepes and 137 mM NaCl (pH 7.4)], and the proteins were eluted with HBS (7.4) containing DDDDK peptide (100 mg/ml; MBL). Fractions containing LM511E8 were concentrated with Amicon Ultra-15 (Merck Millipore) and further purified on a Superdex 200 10/300 GL column (GE Healthcare) using HBS (7.4) as the running buffer.
tLM511E8 for crystallization was produced using FreeStyle 293-F cells and purified by affinity chromatography as for LM511E8. Fractions containing tLM511E8 were concentrated using Amicon Ultra-15 and digested with TEV protease (2000 U/ml) at 25°C for 24 hours. The reaction mixture was subjected to gel filtration on a Superdex 200 10/300 GL column using HBS (7.4) as the running buffer. Fractions containing TEV-digested tLM511E8 were concentrated with Amicon Ultra-2 (Merck Millipore) to~30 mg/ml and stored at −80°C.
Recombinant human a6b1 integrin was prepared as described previously (10, 11) . Intact a6b1 integrin for electron microscopic observation was prepared using the same expression system. The conditioned media were loaded onto ANTI-FLAG M2 Affinity Gel (Sigma-Aldrich), and bound proteins were eluted with HBS (7.4) containing FLAG peptide (100 mg/ml). Fractions containing a6b1 integrin were concentrated with Amicon Ultra-4 (Merck Millipore) and immediately subjected to gel filtration on a Superdex 200 10/300 GL column using HBS (7.4) as the running buffer. Fractions containing a6b1 integrin were collected and stored at −80°C. Protein concentrations of all recombinant products were determined using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) using bovine serum albumin (BSA) as the standard.
Solid-phase integrin binding assay
Binding activities of a6b1 integrin to wild-type and mutant LM511E8s, including tLM511E8, were measured by solid-phase binding assays as follows. LM511E8s were adsorbed onto 96-well microtiter plates (Thermo Fisher Scientific) at 10 nM overnight at 4°C and then blocked with 3% BSA at room temperature for 1 hour. The amounts of LM511E8s adsorbed on the plates were quantified with mAbs 5D6 and 4C7 to confirm the equality of the amounts of adsorbed proteins. After washing once with tris-buffered saline (TBS) [20 mM tris and 137 mM NaCl (pH 7.4)] containing 1 mM MnCl 2 , 0.3% BSA, and 0.02% Tween 20 (Mn 2+ buffer), the plates were incubated with serially diluted a6b1 integrin solution at room temperature for 3 hours in the presence of 1 mM MnCl 2 or 10 mM EDTA. After three washes with Mn 2+ buffer or TBS containing 10 mM EDTA, 0.3% BSA, and 0.02% Tween 20, the plates were incubated with biotinylated rabbit anti-Velcro pAb (1.5 mg/ml) in Mn 2+ buffer at room temperature for 30 min. After three washes with Mn 2+ buffer, the plates were incubated with streptavidin-HRP (0.53 mg/ml) for 15 min. After three washes with Mn 2+ buffer, the amount of bound
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Preparation of laminin-integrin complex
The laminin-integrin complex was formed by mixing 200 pmol of purified LM511E8 and the same amount of purified a6b1 integrin at room temperature for 30 min in HBS (7.4) containing 1 mM MnCl 2 . The complex was subjected to gel filtration on a Superose 6 10/300 GL column (GE Healthcare) preequilibrated with HBS containing 1 mM MnCl 2 . Fractions containing the complex were identified by SDS-PAGE followed by Coomassie Brilliant Blue staining.
Electron microscopy and image processing The fractionated complex was incubated for 1 min at room temperature on glow-discharged carbon-coated grids (Nisshin EM). Samples were washed three times in ultrapure water containing 1 mM MnCl 2 and stained three times with 2% uranyl acetate for 30 s. After vacuum drying, grids were inspected with a Hitachi H-7650 transmission electron microscope operated at 80 kV.
Intermolecular disulfide bond formation between LM511E8 and a6b1 integrin c-Myc-tagged LMa5E8 was used throughout the intermolecular disulfide formation assays. LM511E8/wild type, LM511E8/I1606C, LM511E8/I1606C/EQ, LM511E8/K1608C, and LM511E8/K1608C/ EQ were transiently coexpressed with wild-type or Cys-introduced a6b1 integrin using the FreeStyle 293 Expression System. Seventytwo hours after transfection, conditioned media were incubated with mAb 5D6 (1 mg/ml) at 4°C for 1 hour. Secreted laminin-integrin complexes were precipitated with Protein G Sepharose 4 Fast Flow (GE Healthcare). Immunoprecipitates were analyzed by SDS-PAGE under nonreducing conditions, followed by immunoblotting with anti-c-Myc mAb and anti-Velcro pAb.
Inhibition of a6b1 integrin binding to LM511E8 Wild-type LM511E8 was adsorbed onto 96-well microtiter plates at 10 nM overnight at 4°C and then blocked with 3% BSA at room temperature for 1 hour. Serially diluted synthetic peptide [g1C5 or g1C5(EQ)] or LM511E8 (wild type or Dg1C5) was incubated with 1 nM a6b1 integrin in Mn 2+ buffer containing 3 nM isotype control IgG or integrin b1 activating mAb TS2/16 at room temperature for 1 hour, then added to LM511E8-coated plates, and allowed to bind to LM511E8 at room temperature for 1 hour. After three washes with Mn 2+ buffer, the plates were incubated with biotinylated rabbit anti-Velcro pAb (1.5 mg/ml) in Mn 2+ buffer at room temperature for 30 min. After three washes with Mn 2+ buffer, the plates were incubated with streptavidin-HRP (0.53 mg/ml) for 15 min. After three washes with Mn 2+ buffer, the amount of bound a6b1 integrin was quantified by measuring the absorbance at 490 nm after incubation with o-phenylenediamine.
IC 50 values were calculated using the following equation
where x is peptide or LM511E8 concentration (in micromolars per nanomolar), "y" is activity (in percent) in the presence of inhibitors relative to the activity in the absence of inhibitors, "A" corresponds to the relative activity on the top plateau region of the curve, "B" corresponds to the slope, "C" corresponds to the inflection point of the curve, and "D" corresponds to the relative activity on the bottom plateau region of the curve. To obtain these four parameters, experimental raw data points were fitted to this equation using the "Curve Fitter" tool of ImageJ software (26) . IC 50 values were determined by substituting "y = 50" in the abovementioned equation.
Crystallization and diffraction data collection Crystallization was performed at 20°C. Initial screening of crystallization conditions was performed using The Classics Neo Suite (Qiagen). For this screen, a mosquito crystallization robot (TTP LabTech) was used to dispense 0.5 ml of protein solution mixed in a 1:1 ratio with the reservoir solution. Drops were equilibrated over 80 ml of reservoir solution using the sitting drop vapor diffusion method. The initial crystallization condition [0.2 M ammonium sulfate, 0.1 M sodium acetate (pH 4.6), and 25% polyethylene glycol 4000 at room temperature] was optimized using a 24-well crystallization plate with the hanging drop vapor diffusion method. Each well contained 500 ml of reservoir solution, and the drop volume was a mixture of 0.5 ml of protein solution and 0.5 ml of reservoir solution. Diffraction quality crystals were obtained under conditions of 0.2 M ammonium sulfate, 0.1 M sodium acetate adjusted to pH 4.2 with acetic acid, and 19% polyethylene glycol 4000. Before x-ray diffraction experiments, crystals were soaked in reservoir solution containing an additional 20% glycerol and flash-cooled in liquid nitrogen. The diffraction data set for phasing was collected at BL-1A, Photon Factory (Tsukuba, Japan), and processed using the XDS package (27) . In this data collection, three data sets of 720°each with an oscillation angle of 0.2°were merged. A higher-resolution data set for refinement was collected at BL44XU, SPring-8 (Hyogo, Japan), and processed using the HKL2000 package (28) . The diffraction data statistics are shown in table S1.
Structure determination
The crystal structure of tLM511E8 was solved by the singlewavelength anomalous dispersion method using native crystals. The coordinates of the substructure including the sulfur atoms and the calcium ion were determined using SHELXC and SHELXD (29) . The phase calculation using these coordinates with phase improvement followed by automated initial model building was performed using the PHENIX program package (30). This initial model was then extended and refined by manual editing using COOT (31) , with the iterated implementation of refmac5 (32) on the higher-resolution data set. Finally, the crystal structure was refined to the R/R free factors of 0.202/0.237 at a resolution of 1.80 Å, validated with MOLPROBIDY (33) . Refinement statistics are described in table S1. All figures of the tLM511E8 model in this article were produced using PyMOL (www.pymol.org/).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/9/e1701497/DC1 fig. S1 . Preparation and crystallization of tLM511E8. fig. S2 . Comparison of the crystal structures of tLM511E8 and mini-E8 of LM111. fig. S3 . Electron microscopic imaging of the LM511E8-a6b1 integrin complex. fig. S4 . Cys-substituted residues on bI domain. fig. S5 . Integrin binding activity of wild-type and Cys-substituted LM511E8s. fig. S6 . Disulfide formation between Cys-substituted LM511E8 and a6b1 integrin.
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